To determine whether UBL3 is associated with the HD pathological process, we first conducted IHC staining using postmortem brain tissues from HD patients with the anti-polyglutamine antibody (1C2) and the anti-UBL3 antibody. Here, UBL3 is linked to Huntington disease.